![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SP Carpenter, JM Lasker and JL Raucy
College of Pharmacy, University of New Mexico, Albuquerque 87131, USA.
The mechanisms responsible for ethanol-mediated teratogenesis have not been resolved. However, possible etiologies include the local formation of the teratogen acetaldehyde or oxygen radicals by fetal ethanol- oxidizing enzymes. As alcohol dehydrogenases are expressed at very low concentrations in human embryonic tissues, the ethanol-inducible P450 enzyme, CYP2E1, could be the sole catalyst of fetal ethanol oxidation. With this in mind, we examined the expression of this P450 in liver samples from fetuses ranging in gestational age from 16 to 24 weeks. Immunoblot analysis of fetal liver microsomes revealed the presence of a protein immunoreactive with CYP2E1 antibodies that exhibited a slightly lower molecular weight than that found in adult liver samples. Embryonic CYP2E1 expression was further confirmed by the reverse transcriptase reaction with RNA from a 19-week gestational fetal liver used as template. Catalytic capabilities of human fetal microsomes were assessed by measurement of the rate of ethanol oxidation to acetaldehyde, which were 12-27% of those exhibited by adult liver microsomes. Immunoinhibition studies with CYP2E1 antibodies revealed that the corresponding antigen was the major catalyst of this reaction in both fetal and adult tissues. We then assessed whether embryonic CYP2E1 was, like the adult enzyme, inducible by xenobiotics. Treatment of primary fetal hepatocyte cultures with either ethanol or clofibrate demonstrated a 2-fold increase in CYP2E1 levels compared with untreated cells. Collectively, our results indicate that CYP2E1 is present in human fetal liver, that the enzyme is functionally similar to CYP2E1 from adults, and that fetal hepatocyte CYP2E1 is inducible in culture by xenobiotics, including ethanol. Because fetal CYP2E1 mediates ethanol metabolism, the enzyme may play a pivotal role in the local production of acetaldehyde and free radicals, both of which have potential deleterious effects on the developing fetus.
This article has been cited by other articles:
|
|
 |
|
  D. Roymans, P. Annaert, J. Van Houdt, A. Weygers, J. Noukens, C. Sensenhauser, J. Silva, C. Van Looveren, J. Hendrickx, G. Mannens, et al. EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES Drug Metab. Dispos., July 1, 2005; 33(7): 1004 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Raucy, J. Lasker, K. Ozaki, and V. Zoleta Regulation of CYP2E1 by Ethanol and Palmitic Acid and CYP4A11 by Clofibrate in Primary Cultures of Human Hepatocytes Toxicol. Sci., June 1, 2004; 79(2): 233 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. McCarver Applicability of the Principles of Developmental Pharmacology to the Study of Environmental Toxicants Pediatrics, April 1, 2004; 113(4/S1): 969 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Johnsrud, S. B. Koukouritaki, K. Divakaran, L. L. Brunengraber, R. N. Hines, and D. G. McCarver Human Hepatic CYP2E1 Expression during Development J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 402 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Raucy Regulation of CYP3A4 Expression in Human Hepatocytes by Pharmaceuticals and Natural Products Drug Metab. Dispos., May 1, 2003; 31(5): 533 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Raucy, L. Mueller, K. Duan, S. W. Allen, S. Strom, and J. M. Lasker Expression and Induction of CYP2C P450 Enzymes in Primary Cultures of Human Hepatocytes J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Hines and D. G. McCarver The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 355 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Viollet, M. Yaniv, and M. Pontoglio Embryonic but Not Postnatal Reexpression of Hepatocyte Nuclear Factor 1{alpha} (HNF1{alpha}) Can Reactivate the Silent Phenylalanine Hydroxylase Gene in HNF1{alpha}-Deficient Hepatocytes Mol. Cell. Biol., June 1, 2001; 21(11): 3662 - 3670. [Abstract] [Full Text]
|
|
|
|
|
|
R. N. Hines, Z. Luo, T. Cresteil, X. Ding, R. A. Prough, J. L. Fitzpatrick, S. L. Ripp, K. C. Falkner, N.-L. Ge, A. Levine, et al. Molecular Regulation of Genes Encoding Xenobiotic-Metabolizing Enzymes: Mechanisms Involving Endogenous Factors Drug Metab. Dispos., April 13, 2001; 29(5): 623 - 633. [Abstract] [Full Text]
|
|
|
|
|
|
H. Chen, A. G. Fantel, and M. R. Juchau Catalysis of the 4-Hydroxylation of Retinoic Acids by Cyp3a7 in Human Fetal Hepatic Tissues Drug Metab. Dispos., September 1, 2000; 28(9): 1051 - 1057. [Abstract] [Full Text]
|
|
|
|
|
|
H. Chen, M. R. Brzezinski, A. G. Fantel, and M. R. Juchau Catalysis of Drug Oxidation during Embryogenesis in Human Hepatic Tissues using Imipramine as a Model Substrate Drug Metab. Dispos., November 1, 1999; 27(11): 1306 - 1308. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Brzezinski, H. Boutelet-Bochan, R. E. Person, A. G. Fantel, and M. R. Juchau Catalytic Activity and Quantitation of Cytochrome P-450 2E1 in Prenatal Human Brain J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1648 - 1653. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. Chen, I. George, and K. Sperber Effect of Ethanol on Monocytic Function in Human Immunodeficiency Virus Type 1 Infection Clin. Vaccine Immunol., November 1, 1998; 5(6): 790 - 798. [Abstract] [Full Text]
|
|
|
|
|
|
J. L. Raucy, E. D. Schultz, M. R. Wester, S. Arora, D. E. Johnston, J. L. Omdahl, and S. P. Carpenter Human Lymphocyte Cytochrome P450 2E1, a Putative Marker for Alcohol-Mediated Changes in Hepatic Chlorzoxazone Activity Drug Metab. Dispos., December 1, 1997; 25(12): 1429 - 1435. [Abstract] [Full Text]
|
|
|
|
|
|
S. P. Carpenter, D. D. Savage, E. D. Schultz, and J. L. Raucy Ethanol-Mediated Transplacental Induction of CYP2E1 in Fetal Rat Liver J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1028 - 1036. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
